Related Experiment Video
Updated: Nov 9, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[Assessment of Risk Factors for Atherosclerosis in Individuals of Different Categories of Cardiovascular Risk Using
M Y Zubareva1, P P Malyshev1, A A Ansheles1
1National Medical Research Center of Cardiology, Moscow.
Insights
The Aterostop calculator revealed that many individuals face high cardiovascular disease (CVD) risk, with diabetes mellitus showing exponential increases. Lipid-lowering treatment effectiveness in reaching target low-density lipoprotein cholesterol (LDL-C) levels was inversely proportional to CVD risk.
Area of Science:
- Cardiology
- Preventive Medicine
- Medical Informatics
Background:
- Cardiovascular diseases (CVDs) remain a leading cause of mortality globally.
- Effective risk assessment tools are crucial for timely intervention and prevention strategies.
- The Aterostop calculator offers a novel approach to comprehensive CVD risk evaluation.
Purpose of the Study:
- To evaluate the initial outcomes of utilizing the Aterostop calculator for assessing cardiovascular disease (CVD) risk.
- To analyze major and additional risk factors in individuals with and without established atherosclerotic CVD.
Main Methods:
- A cross-sectional study involving 460 participants (healthy and with diagnosed atherosclerotic CVD).
- Utilized the Aterostop application, developed at the National Medical Research Center of Cardiology, Moscow.
- Assessed risk factors including age, smoking, arterial hypertension, diabetes mellitus (DM), and lipid profiles.
Main Results:
- 45.4% of participants fell into very high and extreme CVD risk categories.
- Arterial hypertension and diabetes mellitus prevalence increased with higher risk categories, with DM showing exponential growth.
- While lipid-lowering medication use was associated with lower LDL-C, achieving target LDL-C levels was significantly poorer in high-risk individuals (3.7% in extreme risk vs. 75% in low risk).
Conclusions:
- The Aterostop calculator's findings align with existing data on the suboptimal effectiveness of primary and secondary prevention of atherosclerotic CVDs.
- There is a critical need for enhanced physician-patient collaboration to improve CVD prevention outcomes.
- The study highlights the importance of accurate risk stratification tools like Aterostop in clinical practice.
Abstract:
Aim To analyze first results of using the Aterostop calculator for a comprehensive evaluation of the risk for cardiovascular diseases (CVD).Material and methods A cross-sectional study analyzed major and additional risk factors in 460 subjects without apparent disease and in patients with documented CVD of atherosclerotic origin using the application (calculator) Aterostop developed in the National Medical Research Center of Cardiology in Moscow, Russia.Results 45.4% of evaluated persons belonged to the categories of very high and extreme risk. Age and frequencies of smoking, arterial hypertension, and diabetes mellitus (DM) increased with the increase in risk; the growth of DM was exponential. 129 (28%) individuals used lipid-lowering medications at the time of study. Their plasma levels of low-density lipoprotein cholesterol (LDL-C) were significantly lower than in those who did not received this treatment. However, achieving the target level was inversely proportional to the risk: the greatest proportion of individuals who reached the LDL-C target was in the category of low risk and the smallest proportion was in the category of extreme risk (75 % vs. 3.7 %, respectively).Conclusion The results obtained with the calculator Aterostop were consistent with earlier reports of insufficient effectiveness of primary and secondary prevention of atherosclerotic CVDs, which requires more tight and fruitful cooperation of the physician and the patient.
More Related Videos
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease IV: Preventive Measures